Villere ST Denis J & Co. LLC lessened its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 32.6% during the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 906,758 shares of the company's stock after selling 437,850 shares during the period. Option Care Health accounts for approximately 3.1% of Villere ST Denis J & Co. LLC's portfolio, making the stock its 10th largest holding. Villere ST Denis J & Co. LLC owned approximately 0.55% of Option Care Health worth $31,691,000 at the end of the most recent quarter.
Several other large investors also recently added to or reduced their stakes in OPCH. Murphy & Mullick Capital Management Corp purchased a new stake in Option Care Health during the fourth quarter valued at about $26,000. Signaturefd LLC increased its position in shares of Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after purchasing an additional 1,005 shares during the last quarter. Quadrant Capital Group LLC increased its position in shares of Option Care Health by 172.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock valued at $40,000 after purchasing an additional 1,099 shares during the last quarter. Public Employees Retirement System of Ohio raised its holdings in shares of Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after buying an additional 332 shares in the last quarter. Finally, Johnson Financial Group Inc. bought a new stake in Option Care Health in the 4th quarter worth approximately $47,000. Institutional investors own 98.05% of the company's stock.
Wall Street Analysts Forecast Growth
Several research firms have commented on OPCH. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their price target for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. JMP Securities reiterated a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a research report on Wednesday, June 18th. JPMorgan Chase & Co. boosted their price target on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. Finally, Barrington Research reaffirmed an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research note on Wednesday, April 30th. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $35.50.
View Our Latest Stock Report on OPCH
Option Care Health Stock Performance
Shares of Option Care Health stock traded down $0.53 during trading on Tuesday, hitting $31.95. 1,401,488 shares of the company's stock traded hands, compared to its average volume of 1,936,602. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The business has a 50-day simple moving average of $32.08 and a 200-day simple moving average of $30.99. The stock has a market capitalization of $5.23 billion, a P/E ratio of 25.77, a PEG ratio of 1.95 and a beta of 0.74. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.54 and a quick ratio of 1.02.
Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. The firm had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a net margin of 4.12% and a return on equity of 16.90%. The business's revenue for the quarter was up 16.3% on a year-over-year basis. During the same period in the previous year, the business posted $0.26 earnings per share. As a group, analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current year.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Articles

Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.